73

Oncology
Prevention and treatment of tumors, and caring for cancer patients.
Sub Categories on Oncology
Latest Articles
Advancing cervical cancer prevention in China: New insights and future strategies

Advancing cervical cancer prevention in China: New insights and future strategies

byChinese Academy of SciencesNumber of areas providing free or subsidized HPV vaccination. Credit:Cancer Biology & Medicine(2024). DOI: 10.20892/j.issn.2095-3941.2023.0432As the

Advancing cervical cancer prevention in China: New insights and future strategies

byChinese Academy of SciencesNumber of areas providing free or subsidized HPV vaccination. Credit:Cancer Biology & Medicine(2024). DOI: 10.20892/j.issn.2095-3941.2023.0432As the
Advances in multiple myeloma treatment

Advances in multiple myeloma treatment

by Jason Howland, Mayo Clinic News NetworkMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0March is Myeloma Awareness Month. Mul

Advances in multiple myeloma treatment

by Jason Howland, Mayo Clinic News NetworkMicrograph of a plasmacytoma, the histologic correlate of multiple myeloma. H&E stain. Credit: Wikipedia/CC BY-SA 3.0March is Myeloma Awareness Month. Mul
A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint

A peptide-drug conjugate that targets the acidic environment of cancer cells may improve the efficacy of immunotherapy

by American Association for Cancer ResearchCredit: Pixabay/CC0 Public DomainA peptide-drug conjugate that targets the acidic environment of cancer cells enhanced the efficacy of immune checkpoint
Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons

Phase 1 study shows novel KRAS inhibitor well tolerated by patients with adenocarcinoma and non-small cell lung cancer

by International Association for the Study of Lung CancerLung CA seen on CXR. Credit:CC BY-SA 4.0James Heilman, MD/WikipediaA clinical trial testing the toxicity of a KRAS inhibitor demons
Massive drug search uncovers infinitesimal molecule that kills cancers while sparing immune cells

Massive drug search uncovers infinitesimal molecule that kills cancers while sparing immune cells

by Delthia Ricks , Medical XpressN6F11 suppresses the growth of human PDAC. (A) PANC1 cells were pretreated with DMSO or N6F11 (5 µM) for 12 hours. (B) MiaPACA2 cells were pretreated with DMSO or N6F1

Massive drug search uncovers infinitesimal molecule that kills cancers while sparing immune cells

by Delthia Ricks , Medical XpressN6F11 suppresses the growth of human PDAC. (A) PANC1 cells were pretreated with DMSO or N6F11 (5 µM) for 12 hours. (B) MiaPACA2 cells were pretreated with DMSO or N6F1
Prognosis of multiple myeloma has improved since 2000

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n

Prognosis of multiple myeloma has improved since 2000

by Elana GotkineFor patients with multiple myeloma (MM), there has been an improvement in prognosis since 2000, but mortality still remains elevated, according to a study published online April 6 in&n
Cancerous brain tumor cells may be at 'critical point' between order and disorder, study suggests

Cancerous brain tumor cells may be at 'critical point' between order and disorder, study suggests

by Noah Fromson,University of MichiganCredit: Justine Ross and Jacob Dwyer / Michigan MedicineGlioblastoma is the most aggressive form of brain cancer. Despite decades of major efforts and clini

Cancerous brain tumor cells may be at 'critical point' between order and disorder, study suggests

by Noah Fromson,University of MichiganCredit: Justine Ross and Jacob Dwyer / Michigan MedicineGlioblastoma is the most aggressive form of brain cancer. Despite decades of major efforts and clini
Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of

Researchers find a new class of biomarkers to predict treatment outcomes in cancer patients

by Kathryn F. Sykes , Medical XpressCancer is the result of the uncontrolled division and spread of cells into surrounding tissue. Recently researchers have begun to focus on biomarkers as a source of
Treatment strategies for adenoid cystic carcinoma of the head and neck

Treatment strategies for adenoid cystic carcinoma of the head and neck

by Impact Journals LLCCT-scan in a coronal section showing an adenoid cystic carcinoma as an inhomogeneous mass in the rightmaxillary sinus with infiltration of neighboring structures. Credit: 2023 Du

Treatment strategies for adenoid cystic carcinoma of the head and neck

by Impact Journals LLCCT-scan in a coronal section showing an adenoid cystic carcinoma as an inhomogeneous mass in the rightmaxillary sinus with infiltration of neighboring structures. Credit: 2023 Du
Fighting cancer with LIGHT, a novel proton accelerator for treatment

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb

Fighting cancer with LIGHT, a novel proton accelerator for treatment

by Kristiane Bernhard-Novotny,CERNModel of the LIGHT accelerator, including treatment room. Credit: AVOCancer irradiation with hadron beams, a method to which CERN contributed by propelling carb
Breast cancer vaccine safely generates anti-tumor immunity

Breast cancer vaccine safely generates anti-tumor immunity

by Michael McCarthy.,University of WashingtonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI C

Breast cancer vaccine safely generates anti-tumor immunity

by Michael McCarthy.,University of WashingtonThree-dimensional culture of human breast cancer cells, with DNA stained blue and a protein in the cell surface membrane stained green. Credit: NCI C
Researchers discover novel way to make breast cancer cells die

Researchers discover novel way to make breast cancer cells die

by Steve Lundeberg,Oregon State UniversityCredit:ACS Pharmacology & Translational Science(2024). DOI: 10.1021/acsptsci.3c00360Oregon State University researchers have discovered

Researchers discover novel way to make breast cancer cells die

by Steve Lundeberg,Oregon State UniversityCredit:ACS Pharmacology & Translational Science(2024). DOI: 10.1021/acsptsci.3c00360Oregon State University researchers have discovered